- HK$4.35bn
- HK$4.85bn
- HK$1.44bn
- 46
- 23
- 12
- 12
2018 December 31st | R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 119 | 147 | 340 | 687 | 1,443 |
Cost of Revenue | |||||
Gross Profit | 95.8 | 105 | 166 | 349 | 591 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 139 | 205 | 223 | 681 | 1,257 |
Operating Profit | -19.8 | -58.2 | 117 | 5.41 | 185 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -19.8 | -63.3 | 67.1 | -14.9 | 92.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.6 | -48.7 | 81.2 | -22.7 | 58.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -19.6 | -48.7 | 81.2 | -22.7 | 42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.6 | -48.7 | 81.2 | -22.7 | 42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.01 | -0.029 | 0.044 | -0.012 | 0.018 |